Home › Funds › TANG CAPITAL MANAGEMENT LLC › ANAB
TANG CAPITAL MANAGEMENT LLC position in ANAB
ANAPTYSBIO INC · Health Care
TANG CAPITAL MANAGEMENT LLC reported holding 1,474,262 shares of ANAB (ANAPTYSBIO INC) in its Q3 2026 13F filing — a position valued at US$74.1M, representing 3.41% of its reported portfolio and ranking #11 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed ANAB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How TANG CAPITAL MANAGEMENT LLC's ANAB position evolved
TANG CAPITAL MANAGEMENT LLC first disclosed a stake in ANAB in Q3 2023 at 1,950,609 shares (US$35.0M). The position peaked in Q2 2026 at 1,330,879 shares, worth US$89.8M. Across 13 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 1,474,262 shares valued at US$74.1M — an increase of 143,383 shares quarter over quarter.. Notable position changes include a 32% trim in Q1 2024 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.95M | $35.03M | New |
| Q4 2023 | 1.95M | $41.78M | Hold |
| Q1 2024 | 1.33M | $29.97M | Reduce |
| Q2 2024 | 1.33M | $33.35M | Hold |
| Q3 2024 | 1.33M | $44.58M | Hold |
| Q4 2024 | 1.33M | $17.62M | Hold |
| Q1 2025 | 1.55M | $28.72M | Add |
| Q2 2025 | 1.33M | $29.55M | Reduce |
| Q3 2025 | 1.33M | $40.84M | Hold |
| Q4 2025 | 1.33M | $64.58M | Hold |
| Q1 2026 | 1.33M | $73.81M | Hold |
| Q2 2026 | 1.33M | $89.83M | Hold |
| Q3 2026 | 1.47M | $74.10M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANAB and 13F data
ANAB (ANAPTYSBIO INC) is a Health Care company. 37 other funds we track also report a position in ANAB — the largest reported positions include EcoR1 Capital, LLC (US$396.1M), Sanofi (US$41.3M), 683 Capital Management, LLC (US$37.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANAB
- EcoR1 Capital, LLC 7.88M sh · $396.05M · Q3 2026
- Sanofi 821.92K sh · $41.31M · Q3 2026
- 683 Capital Management, LLC 740.00K sh · $37.19M · Q3 2026
- Palo Alto Investors LP 595.26K sh · $29.92M · Q3 2026
- Pertento Partners LLP 545.00K sh · $27.39M · Q3 2026
- APIS CAPITAL ADVISORS, LLC 444.00K sh · $22.32M · Q3 2026
- Sofinnova Investments, Inc. 330.40K sh · $16.61M · Q3 2026
- First Light Asset Management, LLC 328.52K sh · $16.51M · Q3 2026
- Irenic Capital Management LP 299.21K sh · $15.04M · Q3 2026
More on TANG CAPITAL MANAGEMENT LLC
FAQ
How long has TANG CAPITAL MANAGEMENT LLC held ANAB?
TANG CAPITAL MANAGEMENT LLC has disclosed ANAB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is TANG CAPITAL MANAGEMENT LLC's current position in ANAB?
As of Q3 2026, TANG CAPITAL MANAGEMENT LLC holds 1.47M shares of ANAB (ANAPTYSBIO INC), valued at $74.10M, representing 3.41% of its reported portfolio and ranking #11.
Has TANG CAPITAL MANAGEMENT LLC been buying or selling ANAB?
In the latest 13F filing (Q3 2026), TANG CAPITAL MANAGEMENT LLC increased its position in ANAB. The position peaked in Q2 2026 at 1.33M shares.
Which other funds hold ANAB?
Other major institutional holders of ANAB include EcoR1 Capital, LLC, Sanofi, 683 Capital Management, LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.